RMDN3 and amyotrophic lateral sclerosis: The regulation of VAPB-PTPIP51 in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) by FUS metabolism defects through GSK3β mediated regulation of complex formation and supports disease development (Stoica et al., 2016).